Scott L Burrows, Chief Financial Officer, on September 01, 2026, sold 25,732 shares in Spyre Therapeutics (SYRE) for $2,283,821. Following the Form 4 filing with the SEC, Burrows has control over a total of 79,762 common shares of the company, with 79,762 shares held directly.
SEC Filing: